113 related articles for article (PubMed ID: 20214630)
1. Irbesartan inhibits albumin-elicited proximal tubular cell apoptosis and injury in vitro.
Matsui T; Yamagishi S; Ueda S; Fukami K; Okuda S
Protein Pept Lett; 2010 Jan; 17(1):74-7. PubMed ID: 20214630
[TBL] [Abstract][Full Text] [Related]
2. Irbesartan inhibits advanced glycation end product (AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs (RAGE) expression.
Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
Pharmacol Res; 2010 Jan; 61(1):34-9. PubMed ID: 19635564
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of metformin and irbesartan on advanced glycation end products (AGEs)-RAGE-induced proximal tubular cell injury.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Pharmacol Res; 2012 Mar; 65(3):297-302. PubMed ID: 22100460
[TBL] [Abstract][Full Text] [Related]
4. Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells.
Wolf G; Schroeder R; Ziyadeh FN; Stahl RA
Kidney Int; 2004 Nov; 66(5):1849-58. PubMed ID: 15496155
[TBL] [Abstract][Full Text] [Related]
5. Irbesartan inhibits advanced glycation end product (AGE)-induced up-regulation of vascular cell adhesion molecule-1 (VCAM-1) mRNA levels in glomerular endothelial cells.
Matsui T; Nishino Y; Maeda S; Takeuchi M; Yamagishi S
Microvasc Res; 2011 May; 81(3):269-73. PubMed ID: 21236267
[TBL] [Abstract][Full Text] [Related]
6. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Horm Metab Res; 2012 Nov; 44(12):891-5. PubMed ID: 22864903
[TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin II type 1 receptor blocker on albumin-induced cell damage in human renal proximal tubular epithelial cells.
Takao T; Horino T; Kagawa T; Matsumoto R; Inoue K; Taguchi T; Morita T; Iwasaki Y; Hashimoto K; Terada Y
Am J Nephrol; 2009; 29(2):102-8. PubMed ID: 18689996
[TBL] [Abstract][Full Text] [Related]
8. Irbesartan attenuates contrast media-induced NRK-52E cells apoptosis.
Xiong XL; Jia RH; Yang DP; Ding GH
Pharmacol Res; 2006 Oct; 54(4):253-60. PubMed ID: 16828304
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells.
Yamagishi S; Inagaki Y; Okamoto T; Amano S; Koga K; Takeuchi M
Kidney Int; 2003 Feb; 63(2):464-73. PubMed ID: 12631112
[TBL] [Abstract][Full Text] [Related]
10. Albumin overload induces adaptive responses in human proximal tubular cells through oxidative stress but not via angiotensin II type 1 receptor.
Shalamanova L; McArdle F; Amara AB; Jackson MJ; Rustom R
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1846-57. PubMed ID: 17327499
[TBL] [Abstract][Full Text] [Related]
11. Effect of irbesartan on angiotensin II-induced hypertrophy of human proximal tubular cells.
Liu BC; Sun J; Chen Q; Luo DD; Ma KL; Ruan XZ
Chin Med J (Engl); 2004 Apr; 117(4):547-51. PubMed ID: 15109447
[TBL] [Abstract][Full Text] [Related]
12. Targeting the proinflammatory cytokines, oxidative stress, apoptosis and TGF-β1/STAT-3 signaling by irbesartan to ameliorate doxorubicin-induced hepatotoxicity.
Kabel AM; Alzahrani AA; Bawazir NM; Khawtani RO; Arab HH
J Infect Chemother; 2018 Aug; 24(8):623-631. PubMed ID: 29753615
[TBL] [Abstract][Full Text] [Related]
13. Sodium-glucose cotransporter 2-mediated oxidative stress augments advanced glycation end products-induced tubular cell apoptosis.
Maeda S; Matsui T; Takeuchi M; Yamagishi S
Diabetes Metab Res Rev; 2013 Jul; 29(5):406-12. PubMed ID: 23508966
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the renin-angiotensin and endothelin systems on progressive renal injury.
Cao Z; Cooper ME; Wu LL; Cox AJ; Jandeleit-Dahm K; Kelly DJ; Gilbert RE
Hypertension; 2000 Oct; 36(4):561-8. PubMed ID: 11040236
[TBL] [Abstract][Full Text] [Related]
15. Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level.
Ishibashi Y; Yamagishi S; Matsui T; Ohta K; Tanoue R; Takeuchi M; Ueda S; Nakamura K; Okuda S
Metabolism; 2012 Aug; 61(8):1067-72. PubMed ID: 22386936
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice.
Yao R; Cheng X; Chen Y; Xie JJ; Yu X; Liao MY; Ding YJ; Tang TT; Liao YH
Int J Cardiol; 2010 Mar; 139(2):113-22. PubMed ID: 19028402
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells.
Gesualdo L; Ranieri E; Monno R; Rossiello MR; Colucci M; Semeraro N; Grandaliano G; Schena FP; Ursi M; Cerullo G
Kidney Int; 1999 Aug; 56(2):461-70. PubMed ID: 10432384
[TBL] [Abstract][Full Text] [Related]
18. Comparison of calycosin and irbesartan for their impact on renin angiotensin system in human umbilical vein endothelial cell.
Li XL; Song RX; Lin X; Ma RX; Bai F; Yu J
Minerva Med; 2015 Feb; 106(1):9-16. PubMed ID: 25423498
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells.
Kagawa T; Takao T; Horino T; Matsumoto R; Inoue K; Morita T; Hashimoto K
Nephrology (Carlton); 2008 Jun; 13(4):309-15. PubMed ID: 18331441
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice.
Kato J; Koda M; Kishina M; Tokunaga S; Matono T; Sugihara T; Ueki M; Murawaki Y
Int J Mol Med; 2012 Jul; 30(1):107-13. PubMed ID: 22469867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
